This study, sponsored by Yale University, investigates the effects of timed therapeutic light on sleep and circadian rhythms in women with Alzheimer's Disease (AD). Given the increasing prevalence of AD, particularly among women, there is a growing market for interventions that address sleep disturbances associated with this condition. The results may position the therapeutic light intervention as a supportive care option, potentially leading to partnerships with device manufacturers or healthcare providers focused on AD management. Competitive implications include the need to assess existing therapies targeting sleep disorders in AD, as well as the potential for intellectual property development around the specific light therapy protocols used in this study.